IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01705-06v1
75/2/801    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huelsenbeck, J.
Right arrow Articles by Genth, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huelsenbeck, J.
Right arrow Articles by Genth, H.
Infection and Immunity, February 2007, p. 801-809, Vol. 75, No. 2
0019-9567/07/$08.00+0     doi:10.1128/IAI.01705-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Difference in the Cytotoxic Effects of Toxin B from Clostridium difficile Strain VPI 10463 and Toxin B from Variant Clostridium difficile Strain 1470{triangledown}

Johannes Huelsenbeck,1 Stefanie Dreger,1 Ralf Gerhard,1 Holger Barth,2 Ingo Just,1 and Harald Genth1*

Institute of Toxicology, Hannover Medical School, D-30625 Hannover, Germany,1 Institute of Pharmacology and Toxicology, University of Ulm Medical Center, D-89081 Ulm, Germany2

Received 25 October 2006/ Returned for modification 3 November 2006/ Accepted 20 November 2006

Glucosylation of RhoA, Rac1, and Cdc42 by Clostridium difficile toxin B from strain VPI 10463 (TcdB) results in actin reorganization (cytopathic effect) and apoptosis (cytotoxic effect). Toxin B from variant C. difficile strain 1470 serotype F (TcdBF) differs from TcdB with regard to substrate proteins, as it glucosylates Rac1 and R-Ras but not RhoA and Cdc42. In this study, we addressed the question of whether the cellular effects of the toxins depend on their protein substrate specificity. Rat basophilic leukemia (RBL) cells were synchronized using the thymidine double-block technique. We show that cells were most sensitive to the cytotoxic effect of TcdB in S phase, as analyzed in terms of phosphatidyl serine externalization, fragmentation of nuclei, and activation of caspase-3; in contrast, TcdBF induced only a marginal cytotoxic effect, suggesting that inactivation of RhoA (but not of Rac1) was required for the cytotoxic effect. The glucosylation of Rac1 was correlated to the cytopathic effect of either toxin, suggesting a close connection of the two effects. The cytotoxic effect of TcdB was executed by caspase-3, as it was responsive to inhibition by acetyl-Asp-Met-Gln-Asp-aldehyde (Ac-DMQD-CHO), an inhibitor of caspase-3. The viability of TcdB-treated RBL cells was reduced, whereas the viability of TcdBF-treated cells was unchanged, further confirming that inactivation of RhoA is required for the cytotoxic effect. In conclusion, the protein substrate specificity of the glucosylating toxins determines their biological activity.


* Corresponding author. Mailing address: Institut für Toxikologie, Medizinische Hochschule Hannover, D-30625 Hannover, Germany. Phone: 49-511-532-9168. Fax: 49-511-532-2879. E-mail: genth.harald{at}mh-hannover.de.

{triangledown} Published ahead of print on 4 December 2006.

Editor: D. L. Burns


Infection and Immunity, February 2007, p. 801-809, Vol. 75, No. 2
0019-9567/07/$08.00+0     doi:10.1128/IAI.01705-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.